---
figid: PMC3382911__onci-1-529-g1
figtitle: Colon cancer cells produce immunoregulatory glucocorticoids
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC3382911
filename: onci-1-529-g1.jpg
figlink: /pmc/articles/PMC3382911/figure/F1/
number: F1
caption: Figure 1. Proposed role of LRH-1 and glucocorticoid synthesis in tumor immune
  evasion. Tumor-infiltrating immune cells, such as T cells, macrophages (MΦ) and
  dendritic cells (DC), release factors, such as TNFα, which stimulate the activation
  of the transcription factor LRH-1 in colorectal tumor cells. LRH-1 regulates the
  transcription of cyclins, leading to tumor cell proliferation, and steroidogenic
  enzymes (cytochrome P450 enzymes, Cyp), leading to the synthesis of glucocorticoids
  (GC). Glucocorticoids in turn suppress the activation of cytotoxic T cells and innate
  immune cells. LRH-1 can also be activated via the MAP kinase (MAPK) pathway upon
  stimulation of growth factor receptors, such as the epidermal growth factor (EGF)
  receptor.
papertitle: Colon cancer cells produce immunoregulatory glucocorticoids.
reftext: Daniel Sidler, et al. Oncoimmunology. 2012 Jul 1;1(4):529-530.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8944435
figid_alias: PMC3382911__F1
figtype: Figure
redirect_from: /figures/PMC3382911__F1
ndex: d772df71-df0d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3382911__onci-1-529-g1.html
  '@type': Dataset
  description: Figure 1. Proposed role of LRH-1 and glucocorticoid synthesis in tumor
    immune evasion. Tumor-infiltrating immune cells, such as T cells, macrophages
    (MΦ) and dendritic cells (DC), release factors, such as TNFα, which stimulate
    the activation of the transcription factor LRH-1 in colorectal tumor cells. LRH-1
    regulates the transcription of cyclins, leading to tumor cell proliferation, and
    steroidogenic enzymes (cytochrome P450 enzymes, Cyp), leading to the synthesis
    of glucocorticoids (GC). Glucocorticoids in turn suppress the activation of cytotoxic
    T cells and innate immune cells. LRH-1 can also be activated via the MAP kinase
    (MAPK) pathway upon stimulation of growth factor receptors, such as the epidermal
    growth factor (EGF) receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PPIG
  - CYP17A1
  - CYP19A1
  - CYP20A1
  - CYP21A2
  - CYP24A1
  - CYP39A1
  - TBXAS1
  - CYP46A1
  - CYP51A1
  - CYP1A1
  - CYP1A2
  - CYP1B1
  - CYP11A1
  - CYP11B1
  - CYP11B2
  - CYP2A13
  - CYP2A6
  - CYP2A7
  - CYP2B6
  - CYP2C18
  - CYP2C19
  - CYP2C8
  - CYP2C9
  - CYP2D6
  - CYP2D7
  - CYP2E1
  - CYP2F1
  - CYP2J2
  - CYP2R1
  - CYP2S1
  - CYP2U1
  - CYP2W1
  - CYP26A1
  - CYP26B1
  - CYP26C1
  - CYP27A1
  - CYP27B1
  - CYP27C1
  - CYP3A4
  - CYP3A43
  - CYP3A5
  - CYP3A7
  - CYP4A11
  - CYP4A22
  - CYP4B1
  - CYP4F11
  - CYP4F12
  - CYP4F2
  - CYP4F22
  - CYP4F3
  - CYP4F8
  - CYP4V2
  - CYP4X1
  - CYP4Z1
  - CYP7A1
  - CYP7B1
  - CYP8B1
  - PTGIS
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - GC
  - NR5A2
  - P2RX5
  - TNF
  - Egf
  - Ppig
  - Gc
  - Nr5a2
  - Tnf
  - egf
  - celsr1a
  - gc
  - lrh1
  - nr5a2
  - tnfrsfa
  - tnfb
---
